他汀类药物应用与胰腺癌的风险一项基于临
2017-6-18 来源:本站原创 浏览次数:次Statinuseandriskofpancreaticcancer:Resultsfromalarge,clinic-basedcase-controlstudy
EJWalker,AHKo,EAHolly,PMBracci
Abstract
Background:Statinsarecholesterol-loweringmedicationswithpleiotropiceffects,includingalterationsingrowthsignaling,aswellasimmunomodulatoryandanti-inflammatoryeffectsthatmayaltercancerrisk.Evidencefrompreviousepidemiologicstudiesisinconsistentaboutwhetherstatinuseisassociatedwithareducedriskofpancreaticcancer(PC).
Methods:PatientswithconfirmeddiagnosesofPC(cases)wererecruitedfrommedicalandsurgicaloncologyclinics,withcontrols(frequency-matchedbysexandage)recruitedfromgeneralmedicineclinics,atahigh-volumeacademicmedicalcenterovera6-yearperiod(-).Directinterviewswereconductedwithanepidemiologicalriskfactorquestionnairecoveringtopicssuchasmedicalhistory,lifestylefactors,andmedicationusage.Adjustedmultivariablelogisticregressionwasusedto白颠疯难治吗北京比较好的治疗白癜风医院